Abridge Analysis: $774M Raised
What is Abridge?
Abridge specializes in transforming clinical conversations into AI-generated notes. Their unique Contextual Reasoning Engine enables real-time, clinically useful documentation. This innovation significantly reduces clinician workload and enhances patient care outcomes.
Employees
201-500
Founded
2018
Industry
SaaS, HealthTech, AI/ML
Product Features & Capabilities
- AI-generated clinical documentation
- Contextual Reasoning Engine for real-time notes
- Integration with Epic for seamless workflows
- Solutions for clinicians, revenue cycle, and nursing
- Impact Calculator for measuring outcomes.
Use Cases
Reduce clinician cognitive load during patient interactions; Improve documentation accuracy and billing efficiency; Enhance clinician focus on patient care; Streamline nursing documentation processes; Support revenue cycle management at the point of care.
How much Abridge raised
Series E - $316M
June 12, 2025Lead Investor: Andreessen Horowitz, Khosla Ventures
Series D - $250M
February 17, 2025Lead Investor: Elad Gil, IVP, Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health, Kaiser Permanente Ventures, Lightspeed Venture Partners, NVentures, Redpoint Ventures, Spark Capital, SV Angel
Series C - $150M
February 22, 2024Lead Investor: Lightspeed Venture Partners, Redpoint Ventures, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Kaiser Permanente Ventures, CVS Health, IVP, Partners HealthCare, Mass General Brigham
Series B - $30M
October 26, 2023Lead Investor: Spark Capital, Bessemer Venture Partners, CVS Health, Kaiser Permanente Ventures, LifePoint Health, Mayo Clinic, American College of Cardiology, University of California
Series A - $12.5M
August 11, 2022Lead Investor: Wittington Ventures, Union Square Ventures, Bessemer Venture Partners, Pillar VC, UPMC, Whistler Capital Partners, Yoshua Bengio
Series A - $15M
October 6, 2020Lead Investor: Union Square Ventures, UPMC, Bessemer Venture Partners, KdT Ventures, Pillar VC
Other Considerations
Recognized as Best in KLAS for 2025; Partners with major healthcare systems like Johns Hopkins and Mayo Clinic; Awarded for innovation in healthcare technology.
Financial Overview
$774MTotal Raised
Series E$316M
June 12, 2025
Investors: Andreessen Horowitz, Khosla Ventures
Series D$250M
February 17, 2025
Investors: Elad Gil, IVP, Bessemer Venture Partners, California Health Care Foundation, CapitalG, CVS Health, Kaiser Permanente Ventures, Lightspeed Venture Partners, NVentures, Redpoint Ventures, Spark Capital, SV Angel
Series C$150M
February 22, 2024
Investors: Lightspeed Venture Partners, Redpoint Ventures, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Kaiser Permanente Ventures, CVS Health, IVP, Partners HealthCare, Mass General Brigham
Series B$30M
October 26, 2023
Investors: Spark Capital, Bessemer Venture Partners, CVS Health, Kaiser Permanente Ventures, LifePoint Health, Mayo Clinic, American College of Cardiology, University of California
Series A$12.5M
August 11, 2022
Investors: Wittington Ventures, Union Square Ventures, Bessemer Venture Partners, Pillar VC, UPMC, Whistler Capital Partners, Yoshua Bengio
Series A$15M
October 6, 2020
Investors: Union Square Ventures, UPMC, Bessemer Venture Partners, KdT Ventures, Pillar VC
